Compare KRYS & DAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRYS | DAR |
|---|---|---|
| Founded | 2015 | 1882 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.4B |
| IPO Year | 2017 | 1994 |
| Metric | KRYS | DAR |
|---|---|---|
| Price | $279.47 | $43.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $250.50 | $45.00 |
| AVG Volume (30 Days) | 299.1K | ★ 2.2M |
| Earning Date | 02-18-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 275.72 | N/A |
| EPS | ★ 6.66 | 0.67 |
| Revenue | $373,164,000.00 | ★ $5,843,771,000.00 |
| Revenue This Year | $36.14 | $5.35 |
| Revenue Next Year | $42.38 | $4.70 |
| P/E Ratio | ★ $41.84 | $62.96 |
| Revenue Growth | ★ 54.51 | N/A |
| 52 Week Low | $122.80 | $26.00 |
| 52 Week High | $295.98 | $43.00 |
| Indicator | KRYS | DAR |
|---|---|---|
| Relative Strength Index (RSI) | 62.12 | 76.37 |
| Support Level | $275.00 | $41.94 |
| Resistance Level | $294.64 | $43.00 |
| Average True Range (ATR) | 11.68 | 1.38 |
| MACD | -0.51 | 0.36 |
| Stochastic Oscillator | 68.67 | 97.11 |
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
Darling Ingredients Inc develops and manufactures sustainable ingredients for customers in the pharmaceutical, food, pet food, fuel, and fertilizer industries. It collects and transforms all aspects of animal by-product streams into ingredients, including gelatin, fats, proteins, pet food ingredients, fertilizers. Also, the company recovers and converts used cooking oil and bakery remnants into feed and fuel ingredients. Darling has three primary business segments which are feed ingredients contributing the majority of revenue, food ingredients, and fuel ingredients. It provides grease trap services for food businesses and sells various equipment for collecting and delivering cooking oil. The company derives the majority of its revenue from customers in North America.